Duncker Streett & Co’s Haleon HLN Stock Holding History

Duncker Streett & Co’s Portfolio HLN Stock Details HLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-83	Closed	-$878	–	542
2024 Q3	$878	Buy	+83	New	+$803	﹤0.01%	460
2024 Q1	–	Sell	-29	Closed	-$239	–	481
2023 Q4	$239	Buy	+29	New	+$239	﹤0.01%	481

Other funds holding HLN

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Duncker Streett & Co's HLN Position: Q4 2024 in Review

Duncker Streett & Co sold out of Haleon (HLN) in Q4 2024, closing a stake of 83 shares — an estimated $878 sold.

Duncker Streett & Co first reported a position in HLN in Q4 2023 and held it in 2 quarters. The position peaked at $878 in Q3 2024. 609 funds tracked by Wall St. Rank hold HLN as of Q4 2024.

Duncker Streett & Co reported no remaining Haleon position as of Q4 2024 after selling out during the quarter.
Duncker Streett & Co sold 83 Haleon shares in Q4 2024, an estimated $878.
Duncker Streett & Co first reported a position in Haleon in Q4 2023 and held it in 2 quarters.
Duncker Streett & Co's Haleon position peaked at $878 in Q3 2024.
609 funds tracked by Wall St. Rank held Haleon as of Q4 2024.

Based on Duncker Streett & Co's 13F filing for Q4 2024, filed 5 Feb 2025.